Cytidine

Cytidine

SCHEMBL2370482

Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1.O=P(O)(O)O.[Na].[Na]

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

POLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PRIM1PRIM2

The experimentally established mechanism targets of Cytidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.88
MTOR P42345 2/20 0.88
THRB P10828 1/20 0.88
MDM2 Q00987 1/20 0.88
NCOA1 Q15788 1/20 0.88
NCOA3 Q9Y6Q9 1/20 0.88
TSHR P16473 1/20 0.58
GLA P06280 1/20 0.58
P2RY2 P41231 1/20 0.58
ALDH1A1 P00352 2/20 0.58
GMNN O75496 1/20 0.58
TP53 P04637 1/20 0.58
NFKB1 P19838 1/20 0.58
DNMT1 P26358 1/20 0.58
THPO P40225 1/20 0.58
HTT P42858 1/20 0.58
RAB9A P51151 1/20 0.58
BLM P54132 1/20 0.58
HBB P68871 1/20 0.58
PMP22 Q01453 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cytarabine SCHEMBL458337 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytarabine SCHEMBL28898416 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytidine SCHEMBL376514 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytarabine SCHEMBL9007590 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytidine SCHEMBL1201153 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytarabine SCHEMBL285195 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytidine SCHEMBL104628 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytidine SCHEMBL39902 0.99 LMNA (0.90) LMNAMTORTHRBMDM2NCOA1
Cytidine SCHEMBL6672407 0.98 LMNA (0.88) LMNAMTORTHRBMDM2NCOA1
Cytarabine SCHEMBL29084328 0.98 LMNA (0.88) LMNAMTORTHRBMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2544553-B2 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN NUTRICIA NV (NL) 2022-11-09 EP claimed
US-10264806-B2 Controlling the texture of high-protein nutritional compositions comprising micellar casein N.V. NUTRICIA (NL) 2019-04-23 US claimed
US-9872888-B2 Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition N.V. NUTRICIA (NL) 2018-01-23 US claimed
EP-2732710-B1 Controlling the texture of high-protein nutritional compositions comprising micellar casein NUTRICIA NV (NL) 2015-07-29 EP claimed
EP-2734060-A1 USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION N.V. Nutricia (NL) 2014-05-28 EP claimed
EP-2732710-A1 Controlling the texture of high-protein nutritional compositions comprising micellar casein N.V. Nutricia (NL) 2014-05-21 EP claimed
US-20140135257-A1 USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION N.V. NUTRICIA 2014-05-15 US claimed
EP-2544553-B1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN NUTRICIA NV (NL) 2014-02-26 EP claimed
US-20130065824-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. NUTRICIA 2013-03-14 US claimed
WO-2013012324-A1 USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION N.V. NUTRICIA (NL) 2013-01-24 WO claimed
WO-2013012313-A1 USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION N.V. NUTRICIA (NL) 2013-01-24 WO claimed
EP-2544553-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. Nutricia (NL) 2013-01-16 EP claimed
WO-2011112075-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. NUTRICIA (NL) 2011-09-15 WO claimed
WO-2011112087-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. NUTRICIA (NL) 2011-09-15 WO claimed
CN-113784706-B Multi-layered pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and B vitamins, their preparation and use 菲尔若国际公司 2024-01-05 CN disclosed
US-20240000124-A1 DAIRY PRODUCT AND PROCESS FONTERRA COOPERATIVE GROUP LTD (NZ) 2024-01-04 US disclosed
EP-4228417-A1 DAIRY PRODUCT AND PROCESS Fonterra Co-Operative Group Limited (NZ) 2023-08-23 EP disclosed
EP-2544553-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. Nutricia (NL) 2013-01-16 EP disclosed
WO-2011112075-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. NUTRICIA (NL) 2011-09-15 WO disclosed
WO-2011112087-A1 CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN N.V. NUTRICIA (NL) 2011-09-15 WO disclosed